Analyst Price Target is $45.00
▲ +24.28% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Fulgent Genetics in the last 3 months. The average price target is $45.00, with a high forecast of $50.00 and a low forecast of $40.00. The average price target represents a 24.28% upside from the last price of $36.21.
Current Consensus is
Buy
The current consensus among 3 contributing investment analysts is to buy stock in Fulgent Genetics. This rating has held steady since September 2021, when it changed from a Hold consensus rating.
Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded on May 13, 2016 and is headquartered in Temple City, CA.
Read More